指南与共识介入

美国放射学会-美国近距离治疗学会-美国放射肿瘤学会低剂量率近距离治疗实践参数

ACR-ABS-ASTRO Practice Parameter for the Performance of Low-Dose-Rate Brachytherapy.
指南 / 共识 · Am J Clin Oncol · 2022-04-29

美国放射学会、美国近距离治疗学会与美国放射肿瘤学会联合制定低剂量率近距离治疗实践参数,按美国放射学会网站所述流程开发,涵盖人员资质、质量保证标准、适应证与文档建议,并包含当代文献检索;该参数用于指导低剂量率近距离治疗的安全有效实施,不评估其相对临床适应证,与其他近距离治疗或外照射的比较费用可能也需考虑。

要点

  • 低剂量率近距离治疗通过在肿瘤内或肿瘤上放置放射源实施治疗,可提高治疗比。
  • 该实践参数涵盖人员资质、质量保证标准、适应证与建议的文档记录。
  • 该参数不评估低剂量率近距离治疗与其他近距离治疗或外照射的相对临床适应证。

核心结论

  • 该实践参数是指导低剂量率近距离治疗使用的工具,不评估其与其他近距离治疗或外照射相比的相对临床适应证,而聚焦于在临床有指征时安全有效实施低剂量率近距离治疗所需的最佳实践。

研究设计与样本

  • 由美国放射学会、美国近距离治疗学会与美国放射肿瘤学会联合制定,按美国放射学会网站所述「美国放射学会实践参数与技术标准制定流程」开发,包含当代文献检索。

临床应用与阅片要点

  • 该实践参数涵盖低剂量率近距离治疗的临床实施,包括人员资质、质量保证标准、适应证与建议的文档记录。
  • 该参数聚焦于在临床有指征时安全有效实施低剂量率近距离治疗所需的最佳实践。
  • 该参数不评估低剂量率近距离治疗与其他近距离治疗或外照射相比的相对临床适应证。
  • 与其他模式治疗相比的比较费用可能也需考虑。

局限性

  • 该实践参数不评估低剂量率近距离治疗与其他近距离治疗或外照射相比的相对临床适应证。
  • 与其他模式治疗相比的比较费用可能也需考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM/OBJECTIVES/BACKGROUND: The American College of Radiology (ACR), the American Brachytherapy Society (ABS), and the American Society for Radiation Oncology (ASTRO) have jointly developed the following practice parameter for the performance of low-dose-rate (LDR) brachytherapy. LDR brachytherapy is the application of radioactive sources in or on tumors in a clinical setting with therapeutic intent. The advantages of LDR brachytherapy include improving therapeutic ratios with lower doses to nontarget organs-at-risk and higher doses to a specific target.

METHODS: This practice parameter was developed according to the process described under the heading. The Process for Developing ACR Practice Parameters and Technical Standards on the ACR website (https://www.acr.org/Clinical-Resources/Practice-Parameters-and-Technical-Standards) by the Committee on Practice Parameters-Radiation Oncology of the Commission on Radiation Oncology, in collaboration with ABS and ASTRO.

RESULTS: This practice parameter was developed to serve as a tool in the appropriate application of this evolving technology in the care of cancer patients or other patients with conditions where radiation therapy is indicated. It addresses clinical implementation of LDR brachytherapy including personnel qualifications, quality assurance standards, indications, and suggested documentation. This includes a contemporary literature search.

CONCLUSIONS: This practice parameter is a tool to guide the use of LDR brachytherapy and does not assess relative clinical indication for LDR brachytherapy when compared with other forms of brachytherapy or external beam therapy, but to focus on the best practices required to deliver LDR brachytherapy safely and effectively, when clinically indicated. Comparative costs of versus other modalities therapy may also need to be considered.

来源:Am J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Woodhouse, Devlin, Kollmeier, et al. ACR-ABS-ASTRO Practice Parameter for the Performance of Low-Dose-Rate Brachytherapy. Am J Clin Oncol. 2022. PMID: 35485607. doi:10.1097/COC.0000000000000912

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。